Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$173,248
+$137,337 QoQ
Shares Held
135,350
+461.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#105
of 258 holders
Holding Since
Sep 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. GERN ranks #106 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in GERN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,248 | 135,350 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $35,911 | 24,102 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,227 | 15,324 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,046,010 | 763,511 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $617,290 | 437,795 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $454,113 | 285,606 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $374,532 | 105,800 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,551,968 | 782,372 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $659,031 | 155,432 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $968,206 | 293,396 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $171,732 | 70,964 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $145,138 | 62,025 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||